(Q28165999)

English

Adjunctive Pharmacotherapy before Percutaneous Coronary Intervention in Non-ST-Elevation Acute Coronary Syndromes: The Role of Modulating Inflammation

scientific article (publication date: 21 October 2003)

In more languages

Statements

scholarly article

0 references

1 reference

Europe PubMed Central

Adjunctive pharmacotherapy before percutaneous coronary intervention in non-ST-elevation acute coronary syndromes: the role of modulating inflammation (English)

0 references

Adjunctive Pharmacotherapy before Percutaneous Coronary Intervention in Non-ST-Elevation Acute Coronary Syndromes: The Role of Modulating Inflammation (English)

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

0 references

pharmacotherapy

0 references

acute coronary syndrome

1 reference

based on heuristic

inferred from title

coronary balloon angioplasty

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14605016

30 March 2024

Cardiology and cardiovascular medicine

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

Dean J Kereiakes

1

object named as

Dean J Kereiakes

0 references

language of work or name

0 references

publication date

21 October 2003

0 references

full work available at URL

https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.0000086951.09881.51

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14605016

30 March 2024

http://intl-circ.ahajournals.org/cgi/content/abstract/108/16_suppl_1/III22

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14605016

30 March 2024

https://www.ahajournals.org/doi/full/10.1161/01.CIR.0000086951.09881.51

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

0 references

108

0 references

16 Suppl 1

0 references

III22-7

0 references

Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1161/01.CIR.0000025609.13806.31

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

1

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

Systemic inflammation in unstable angina is the result of myocardial necrosis

4

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial

5

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients

6

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

Widespread coronary inflammation in unstable angina

7

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

Morphological predictors of restenosis after coronary stenting in humans

10

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

Macrophage depletion by clodronate-containing liposomes reduces neointimal formation after balloon injury in rats and rabbits

12

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina

13

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

Immunosuppressive Therapy for the Prevention of Restenosis after Coronary Artery Stent Implantation (IMPRESS Study).

14

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice g

15

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

Effect of low-dose aspirin on vascular inflammation, plaque stability, and atherogenesis in low-density lipoprotein receptor-deficient mice

16

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

17

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

18

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein

19

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

Journal of the American College of Cardiology

21

41

24A.

publication date

2003

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

Clopidogrel does not suppress blood markers of coagulation activation in aspirin-treated patients with non-ST-elevation acute coronary syndromes

22

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

Comparison of enoxaparin versus unfractionated heparin in patients with unstable angina pectoris/non-ST-segment elevation acute myocardial infarction having subsequent percutaneous coronary intervention

25

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide

26

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

Platelet glycoprotein IIb/IIIa inhibitors: recognition of a two-edged sword?

29

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization

31

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

Journal of the American College of Cardiology

33

41

233A.

publication date

2003

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

Platelet-derived CD40L: the switch-hitting player of cardiovascular disease

34

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

Intravenous glycoprotein IIb/IIIa receptor antagonists reduce mortality after percutaneous coronary interventions

36

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

CD40 ligand--assessing risk instead of damage?

38

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

Activated monocytes induce smooth muscle cell death: role of macrophage colony-stimulating factor and cell contact

39

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

Chimeric 7E3 Fab (ReoPro) decreases detectable CD11b on neutrophils from patients undergoing coronary angioplasty

40

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content

41

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction

42

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

Withdrawal of statins increases event rates in patients with acute coronary syndromes

43

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

Effect of atorvastatin (80 mg) initiated at the time of coronary artery stent implantation on C-reactive protein and six-month clinical events

44

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

Simvastatin inhibits inflammatory properties of Staphylococcus aureus alpha-toxin

45

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

Simvastatin reduces neointimal thickening in low-density lipoprotein receptor-deficient mice after experimental angioplasty without changing plasma lipids

46

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

Journal of the American College of Cardiology

47

39

32A.

publication date

2002

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

Journal of the American College of Cardiology

48

39

32A.

publication date

2002

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

Statin treatment following coronary artery stenting and one-year survival

50

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

Relation of inflammation and benefit of statins after percutaneous coronary interventions

51

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

Evidence that angiotensin-converting enzyme inhibitor use diminishes the need for coronary revascularization after stenting

52

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

Angiotensin-converting enzyme inhibition reduces monocyte chemoattractant protein-1 and tissue factor levels in patients with myocardial infarction

53

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

Evidence-based risk stratification to target therapies in acute coronary syndromes

55

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

Clinical implications of percutaneous coronary intervention-clopidogrel in unstable angina to prevent recurrent events (PCI-CURE) study: a US perspective

56

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

Platelet glycoprotein IIb/IIIa receptor blockers: An appropriate-use model for expediting care in acute coronary syndromes

57

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting

58

1 reference

10.1161/01.CIR.0000086951.09881.51

https://api.crossref.org/works/10.1161/01.CIR.0000086951.09881.51

30 March 2024

Identifiers

10.1161/01.CIR.0000086951.09881.51

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28165999&oldid=2175353748"